BUZZ-U.S. STOCKS ON THE MOVE-Juno Therapeutics, Sony, Pep Boys
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) Wall Street was set to open higher on Tuesday, a day after the Dow and the S&P 500 registered their worst session since October, as investors hoped Greece would strike a last-minute deal to avoid an exit from the euro zone. Dow Jones industrial average e-mini futures were up 0.51 percent at 17,610, S&P 500 futures were up 0.68 percent at 2,064.5 and Nasdaq 100 futures were up 0.50 percent at 4,399.75.
** JUNO THERAPEUTICS INC, Tuesday close $46.3, +31.36 pct premarket
** CELGENE CORP, Tuesday close $114.91, +0.08 pct premarket
** KITE PHARMA, Tuesday close $58.96, +6.04 pct premarket
** ZIOPHARM ONCOLOGY INC, Tuesday close $11.54, +5.03 pct premarket
** CELYAD SA, Tuesday close $50.36, +8.16 pct premarket
** CELLECTIS SA, Tuesday close $33.26, +9.71 pct premarket
Shares of CAR-T cell therapy developers rose after Juno's 10-year agreement with Celgene.
Celgene, on Monday, launched a 10-year partnership with Juno Therapeutics, announcing a $1 billion investment aimed at bringing to market Juno technologies that harness the immune system to treat cancer and autoimmune diseases. Continued...